PCN174 Health Economics And Radium-223 (Xofigo®) In The Treatment Of Metastatic Castration-Resistant Prostate Cancer (Mcrpc). A Case History And A Systematic Review Of The Literature On Cost-Effectiveness Analysis (Cea)
- Publication date
- 30 November 2015
- Publisher
- Published by Elsevier Inc.